Plain-English translation of NCT05921279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Some breast cancer chemotherapy drugs, including anthracycline-based chemotherapy and Herceptin, can affect heart function in some patients. This study is setting up a heart monitoring program to watch for these effects early while women receive their cancer treatment. By catching heart problems sooner, doctors hope to prevent serious complications.
Cancer doctors and heart doctors don't always work together closely, and heart problems from chemotherapy are sometimes missed until they become serious. This study wants to see if regular heart check-ups during cancer treatment can catch these problems early, when they're easier to treat.
You likely qualify if…
You likely don't qualify if…
You will have heart check-ups at baseline, then at 3, 6, and 12 months during and after your chemotherapy. These visits include heart ultrasounds, ECGs (heart rhythm tracings), blood tests, and questionnaires about your quality of life and physical activity. Depending on your heart disease risk level (determined by your doctors), you may have more frequent or intensive monitoring. The whole study lasts about 24 months.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Ireland